C57BL/6N-Fbxo11tm2a(EUCOMM)Wtsi/H

Status

Available to order

EMMA IDEM:06999
International strain nameC57BL/6N-Fbxo11tm2a(EUCOMM)Wtsi/H
Alternative nameEPD0248_1_H03
Strain typeTargeted Mutant Strains
Allele/Transgene symbolFbxo11tm2a(EUCOMM)Wtsi
Gene/Transgene symbolFbxo11
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider MRC, Medical Research Council
Provider affiliationMary Lyon Centre at MRC Harwell
Genetic informationThis mouse line originates from EUCOMM ES clone EPD0248_1_H03. For further details on the construction of this clone see the page at the IMPC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
ReferencesNone available

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom

Disease and phenotype information

IMPC phenotypes (gene matching)
  • decreased prepulse inhibition / IMPC
  • increased lean body mass / IMPC
  • decreased hematocrit / IMPC
  • thrombocytopenia / IMPC
  • decreased circulating iron level / IMPC
  • decreased heart weight / IMPC
  • increased total body fat amount / IMPC
  • abnormal startle reflex / IMPC
  • abnormal defecation / IMPC
  • abnormal locomotor activation / IMPC
  • increased startle reflex / IMPC
  • hyperactivity / IMPC
  • abnormal vocalization / IMPC
  • decreased hemoglobin content / IMPC
  • narrow eye opening / IMPC
  • preweaning lethality, complete penetrance / IMPC
  • decreased mean corpuscular volume / IMPC
  • increased bone mineral content / IMPC
  • decreased circulating calcium level / IMPC
  • decreased lean body mass / IMPC
  • decreased circulating triglyceride level / IMPC
  • decreased circulating total protein level / IMPC
  • decreased erythrocyte cell number / IMPC
  • short tibia / IMPC
  • abnormal retina morphology / IMPC
  • increased fasting circulating glucose level / IMPC
  • increased red blood cell distribution width / IMPC
  • decreased bone mineral density / IMPC
  • abnormal bone mineralization / IMPC
MGI phenotypes (allele matching)
  • decreased hair follicle number / MGI
  • thick epidermis / MGI
  • epidermal hyperplasia / MGI
  • abnormal protein level / MGI
  • absent keratohyalin granules / MGI
  • neonatal lethality, complete penetrance / MGI
MGI phenotypes (gene matching)
  • midline facial cleft / MGI
  • cleft palate / MGI
  • decreased hair follicle number / MGI
  • short snout / MGI
  • thick epidermis / MGI
  • epidermal hyperplasia / MGI
  • decreased body weight / MGI
  • decreased body size / MGI
  • eyelids open at birth / MGI
  • abnormal pinna reflex / MGI
  • decreased startle reflex / MGI
  • increased susceptibility to otitis media / MGI
  • deafness / MGI
  • abnormal cytokine secretion / MGI
  • abnormal auditory tube / MGI
  • decreased endocochlear potential / MGI
  • abnormal middle ear ossicle morphology / MGI
  • hearing/vestibular/ear phenotype / MGI
  • impaired hearing / MGI
  • absent pinna reflex / MGI
  • abnormal protein level / MGI
  • absent keratohyalin granules / MGI
  • neonatal lethality, complete penetrance / MGI
  • neonatal lethality, incomplete penetrance / MGI
  • perinatal lethality, incomplete penetrance / MGI
  • short face / MGI
  • abnormal tympanic cavity morphology / MGI
  • middle ear polyps / MGI
  • middle ear effusion / MGI
  • tympanic membrane retraction / MGI
  • excessive cerumen / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).